Substantia nigra is affected in –
First, I need to recall the core concept. The substantia nigra is part of the midbrain and is crucial for motor control. It's involved in the production of dopamine. So, any disease that affects dopamine neurons here would be relevant.
Parkinson's disease is the classic one here. In PD, there's degeneration of dopaminergic neurons in the substantia nigra pars compacta. This leads to decreased dopamine levels in the striatum, causing the motor symptoms like tremors, rigidity, and bradykinesia.
But what about other options? Let's say the options are Huntington's disease, Alzheimer's, MS, or something else. Huntington's affects the caudate nucleus and putamen, not the substantia nigra. Alzheimer's primarily involves the hippocampus and amyloid plaques. Multiple sclerosis is an autoimmune disease affecting myelinated sheaths in the CNS, but not specifically the substantia nigra. Wilson's disease affects the basal ganglia but more the globus pallidus. So if any of these are options, they're incorrect.
Clinical pearl: Parkinson's disease's hallmark is the loss of dopaminergic neurons in the substantia nigra. Remember that "Parkinson's = substantia nigra gone bad."
**Core Concept**
The **substantia nigra** is a midbrain structure critical for motor control via dopamine production. Its degeneration leads to **Parkinson’s disease (PD)**, characterized by bradykinesia, rigidity, and tremors due to reduced dopamine in the striatum.
**Why the Correct Answer is Right**
In **Parkinson’s disease**, **dopaminergic neurons in the substantia nigra pars compacta** undergo progressive degeneration. This loss disrupts the basal ganglia circuitry, reducing dopamine synthesis and release into the **striatum (caudate and putamen)**. The resulting imbalance between dopaminergic and cholinergic systems causes motor dysfunction. Pathologically, **Lewy bodies** (alpha-synuclein aggregates) are hallmark inclusions in affected neurons.
**Why Each Wrong Option is Incorrect**
**Option A:** *Huntington’s disease* affects the **caudate nucleus and putamen**, not the substantia nigra.
**Option B:** *Alzheimer’s disease* primarily involves **amyloid-beta plaques** and **neurofibrillary tangles** in the hippocampus and neocortex.
**Option C:** *Multiple sclerosis* causes **demyelination** in the CNS, not neuronal loss in the substantia nigra.
**Option D:** *Wilson’s disease* targets the **globus pallidus** and **liver**, not the substantia nigra.
**Clinical Pearl / High-Yield Fact**
Parkinson’s disease is the **prototypical disorder of substantia nigra degeneration**. Remember: **“Dopamine deficiency = Parkinson’s motor symptoms”**. The **loss of pigmented neurons** in the substantia nigra (hence the name) is a key histopathologic finding.
**Correct